News Medical: Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies For many years, women with multiple sclerosis (MS) were advised not to become pregnant because of concerns about relapses after childbirth. But research now shows that pregnancy doesn't make MS worse, ... Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body.
From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ... At least 30 minutes of summer sun per day in the first year of life is linked to a lower relapse risk in children with multiple sclerosis (MS). The findings were published in Neurology Neuroimmunology ...
relapses in multiple sclerosis, — Full results of two phase 3 trials evaluating the effect of oral BG-12 (dimethyl fumarate, Biogen Idec) in patients with multiple sclerosis (MS) show the investigational agent ... New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of ... Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ... Overall, people with multiple sclerosis (MS) were not at increased risk of relapse after receiving booster doses of the COVID-19 vaccine, according to a large nationwide study in France.
